Should health technology assessment (HTA) processes consider using distributional cost effectiveness analysis (DCEA) to incorporate technology impacts on inequality? Some say ‘yes’ and some say ‘no’. Let’s take a look at both sides. No In a Letter to the Editor in Value in Health, Sreeram Ramagopalan noted that NICE currently has a number of concerns…
Capital Rx has secured a $400 million investment, including a $252 million Series F round led by Wellington Management and General Catalyst. It is also rebranding as Judi Health to reflect its expansion beyond pharmacy benefits. The post Capital Rx Rebrands as Judi Health After Securing $400M Investment appeared first on MedCity News.
Capital Rx has secured a $400 million investment, including a $252 million Series F round led by Wellington Management and General Catalyst. It is also rebranding as Judi Health to reflect its expansion beyond pharmacy benefits. The post Capital Rx Rebrands as Judi Health After Securing $400M Investment appeared first on MedCity News.
Sutter Health is rolling out Hyro’s AI agents, which give patients 24/7 support for things like scheduling, prescription refills and billing questions. These agents aim to make routine healthcare interactions faster and easier, while also freeing up staff to handle more complex cases and providing data insights to improve the overall patient experience. The post…
Sutter Health is rolling out Hyro’s AI agents, which give patients 24/7 support for things like scheduling, prescription refills and billing questions. These agents aim to make routine healthcare interactions faster and easier, while also freeing up staff to handle more complex cases and providing data insights to improve the overall patient experience. The post…
This brief describes five key takeaways from CMS’s Notice of Funding Opportunity for the $50 billion Rural Health Transformation Program. It includes information about how CMS intends to review state applications and distribute funds and ongoing questions about the impact on rural hospitals, the distribution of funds across rural hospitals and states, and issues related…
This policy watch reviews recent changes in federal datasets by the Trump administration, including removal of data or variables relating to race or ethnicity or sexual orientation and gender identity.
Ionis Pharmaceuticals plans a 2026 FDA submission for zilganersen as a treatment for Alexander disease, an ultra-rare inherited neurological disorder. The antisense oligonucleotide developer has been moving toward commercializing drugs on its own rather than seeking partners. The post Ionis Pharma’s Drug for Rare Disease With No Approved Therapies Meets Goals of Pivotal Study appeared…
Fighting cancer is hard enough. Everyone deserves to heal in a clean, peaceful space. How one Crothall team is bringing comfort and control to patients in treatment When you’re in the middle of treatment for gynecologic cancer, even simple things like cleaning your home or apartment can feel impossible. “Because I was mentally foggy from…
Successful healthcare innovators harness behavioral science to achieve adoption and behavior change. The post Nudges, Not Information, For Engagement And Adoption appeared first on MedCity News.